Loading…
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
PACT Act of 2019
Client: COALITION FOR PEDIATRIC MEDICAL RESEARCH · Firm: FAEGRE BAKER DANIELS CONSULTING
Fiscal Year 2020 Labor HHS appropriations and report language related to Pediatric Physician Scientist Training Program; implementation of Trans-NIH Pediatric Research Consortium; HR 4519: Pediatricians Accelerate Childhood Therapies Act
American Dream and Promise Act of 2019
Client: NATIONAL ASSOCIATION OF BOARDS OF PHARMACY · Firm: FAEGRE BAKER DANIELS CONSULTING
Medication safety, pharmacy regulation, and the opioid epidemic; Prescription drug monitoring programs: H.R. 6 SUPPORT Act
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
NATIONAL ASSOCIATION OF BOARDS OF PHARMACY via FAEGRE BAKER DANIELS CONSULTING
2019 · third_quarter · Q3
Pharmacy regulation; Prescription drug monitoring
Medication safety, pharmacy regulation, and the opioid epidemic; Prescription drug monitoring programs: H.R. 6 SUPPORT Act
Filing targets: Centers For Disease Control & Prevention (CDC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ), SENATE
Source: Senate LDA
American Dream and Promise Act of 2019
Client: NATIONAL ASSOCIATION OF BOARDS OF PHARMACY · Firm: FAEGRE BAKER DANIELS CONSULTING
Medication safety, pharmacy regulation, and the opioid epidemic; Prescription drug monitoring programs: H.R. 6 SUPPORT Act
American Dream and Promise Act of 2019
Client: NATIONAL ASSOCIATION OF BOARDS OF PHARMACY · Firm: FAEGRE BAKER DANIELS CONSULTING
Medication safety, pharmacy regulation, and the opioid epidemic; Prescription drug monitoring programs: H.R. 6 SUPPORT Act
THERMO FISHER SCIENTIFIC via FAEGRE BAKER DANIELS CONSULTING
2019 · third_quarter · Q3
Asthma policies and diagnostic allergy test coverage; Removing Barriers to Allergy Diagnostics Testing Act of 2019
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
COALITION FOR PEDIATRIC MEDICAL RESEARCH via FAEGRE BAKER DANIELS CONSULTING
2019 · third_quarter · Q3
Fiscal Year 2020 Labor HHS appropriations and report language related to Pediatric Physician Scientist Training Program; implementation of Trans-NIH Pediatric Research Consortium; HR 4519: Pediatricians Accelerate Childhood Therapies Act
Filing targets: HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
BOSTON CHILDREN'S HOSPITAL via FAEGRE BAKER DANIELS CONSULTING
2019 · third_quarter · Q3
Opioid workforce issues with a focus on programs to support addiction medicine fellowships.
Accelerating Kids' Access to Care Act and reintroduction and amendment to bill in 116th Congress; Other issues related to out-of-state Medicaid enrollment.
Funding for medical research; NIH funding; policies to enhance pediatric research activities; implementation of Trans-NIH Pediatric Research Consortium.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
COALITION FOR PEDIATRIC MEDICAL RESEARCH via FAEGRE BAKER DANIELS CONSULTING
2019 · second_quarter · Q2
Fiscal Year 2020 Labor HHS appropriations and report language related to Pediatric Physician Scientist Training Program; implementation of Trans-NIH Pediatric Research Consortium
Filing targets: HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
BOSTON CHILDREN'S HOSPITAL via FAEGRE BAKER DANIELS CONSULTING
2019 · second_quarter · Q2
Opioid workforce issues with a focus on programs to support addiction medicine fellowships.
Funding for medical research; NIH funding; policies to enhance pediatric research activities; implementation of Trans-NIH Pediatric Research Consortium.
Accelerating Kids' Access to Care Act and reintroduction and amendment to bill in 116th Congress; Other issues related to out-of-state Medicaid enrollment.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
THERMO FISHER SCIENTIFIC via FAEGRE BAKER DANIELS CONSULTING
2019 · second_quarter · Q2
Asthma policies and diagnostic allergy test coverage; Removing Barriers to Allergy Diagnostics Testing Act of 2019
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
NATIONAL ASSOCIATION OF BOARDS OF PHARMACY via FAEGRE BAKER DANIELS CONSULTING
2019 · second_quarter · Q2
Pharmacy regulation; Prescription drug monitoring
Medication safety, pharmacy regulation, and the opioid epidemic; Prescription drug monitoring programs: H.R. 6 SUPPORT Act
Filing targets: Centers For Disease Control & Prevention (CDC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ), SENATE
NATIONAL ASSOCIATION OF BOARDS OF PHARMACY via FAEGRE BAKER DANIELS CONSULTING
2019 · first_quarter · Q1
Pharmacy regulation; Prescription drug monitoring
Medication safety, pharmacy regulation, and the opioid epidemic; Prescription drug monitoring programs: H.R. 6 SUPPORT Act
Filing targets: Centers For Disease Control & Prevention (CDC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ), SENATE